SCHEMBL24256501

SCHEMBL24256501

c1ccc(COC[C@H]2OCC[C@@H](OCc3ccccc3)[C@H]2OCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.52
ACHE P22303 2/20 0.52
PDE4D Q08499 1/20 0.43
HTR1A P08908 1/20 0.41
SSTR1 P30872 2/20 0.40
SSTR2 P30874 2/20 0.40
SSTR4 P31391 2/20 0.40
SSTR3 P32745 2/20 0.40
SSTR5 P35346 2/20 0.40
SLC6A2 P23975 1/20 0.40
GJB2 P29033 2/20 0.39
NT5E P21589 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22640958 1.00 BCHE (0.52) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL22640962 1.00 BCHE (0.52) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL18857344 1.00 BCHE (0.52) BCHEACHEPDE4DHTR1ASSTR1
Ammonia Solution, Strong SCHEMBL23705109 0.99 BCHE (0.51) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL18666873 0.90 BCHE (0.49) BCHEACHEPDE4DHTR1ASLC6A2
SCHEMBL18896702 0.86 BCHE (0.55) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL18640660 0.86 BCHE (0.55) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL29937530 0.86 BCHE (0.55) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL22316285 0.86 BCHE (0.55) BCHEACHEPDE4DHTR1ASSTR1
SCHEMBL19380966 0.86 BCHE (0.55) BCHEACHEPDE4DHTR1ASSTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050020-A1 INVARIANT NATURAL KILLER T-CELL ACTIVATORS DECIDUOUS THERAPEUTICS, INC. (US) 2024-03-07 WO disclosed
EP-4097138-A1 ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS Avila Therapeutics, Inc. (US) 2022-12-07 EP disclosed
CN-115066438-A ASGPR binding compounds for degrading extracellular proteins 阿维拉治疗公司 2022-09-16 CN disclosed
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 WO disclosed